Risk assessment and uncertainty approximation are two major and important parameters that need to be adopted for the development of pharmaceutical process to en
Simvastatin (SIM) is a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor widely used in hyperlipidemia therapy. SIM has recently been studied for its an